Swift & Data Structures
Master Swift fundamentals, iOS-specific algorithms, and common data structure problems. Focus on array manipulation, string processing, and tree traversals.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Focus areas that matter most for mobile development positions. Explore key insights and preparation tips to help you excel in your interview process.
Master Swift fundamentals, iOS-specific algorithms, and common data structure problems. Focus on array manipulation, string processing, and tree traversals.
Design scalable iOS applications with proper architecture patterns, data persistence, and network layer design.
Architecture
MVVM, VIPER, Clean Architecture
Data Flow
Core Data, networking, caching
Performance
Memory management, threading
Different companies emphasize different aspects of iOS development based on their product needs and scale.
Apple
Deep iOS frameworks, performance optimization
Uber
Real-time data, location services, scalability
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers approximately 65% lower housing costs compared to San Francisco, with median home prices around $200K versus $1.2M+ in the Bay Area. Your iOS engineer salary stretches significantly further while maintaining access to quality amenities and a growing tech ecosystem.
Baltimore's iOS engineer market is significantly less crowded than major tech hubs, offering better opportunities for career advancement and employer choice.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States